Loading viewer...
investor_presentation
Format: PDF investor_presentation
1 investor.arrow.com Third Quarter 2021 CFO Commentary As reflected in our earnings release, there are a number of items that impact the comparability of our results with those in the trailing quarter and prior quarter of last year. The discussion of our results may exclude these
1 investor.arrow.com
As reflected in our earnings release, there are a
number of items that impact the comparability of
our results with those in the trailing quarter and
prior quarter of last year. The discussion of our
results may exclude these items to give you a
better sense of our operating results. As always,
the operating information we provide to you
should be used as a complement to GAAP
numbers. For a complete reconciliation between
our GAAP and non-GAAP results, please refer to
our earnings release and the earnings
reconciliation found at the end of this document.
The following reported and non-GAAP
information included in this CFO commentary is
unaudited and should be read in conjunction with
the company’s Form 10-Q for the quarterly period
ended October 2, 2021 , and the Annual Report
on Form 10-K as filed with the Securities and
Exchange Commission.Third -quarter 2021
diluted earnings per
year over year; non-
over yearThird -Quarter 2021 CFO Commentary
2 investor.arrow.com
Third -Quarter Summary
Third-quarter results benefited from continued strong demand for electronic
components and associated design, engineering and supply chain services.
However, both global components and enterprise computing solutions were
limited by the current shortfall between semiconductor and electronic
component supply and demand from products with growing electronic content.
Preview truncated — download the full document for the complete content.
45 Pages
investor_presentation
36 Pages
Tiger Logistics (India) Limited
Samsung Mobile Investor Presentation 2021
investor_presentationinvestor_presentation
29 Pages
Samsung Electronics Co., Ltd.
investor_presentation
APA Group
Teva Pharmaceutical Industries Investor Presentation — February 2020
investor_presentationinvestor_presentation
47 Pages
Teva Pharmaceutical Industries